![](https://porib.com/wp-content/uploads/2021/07/Expert-Review-of-Ophthalmology.jpg)
Martínez-de-la-Casa JM, Amaro-Barra A, Teus MA, Vila-Arteaga J, Oyagüez I, Martínez C
Budget Impact Analysis of Xen Gel Implant for Glaucoma Treatment
Expert Review of Ophthalmology 2019;14: 1, 5–13
![](https://porib.com/wp-content/uploads/2021/07/journal_of_medical_economics-1.jpg)
Berlana D, Asunción Mª, Reyes M, Fernández A, Torralba A, Cervera-Peris, Piñeiro G, Romero-Jiménez R, Vázquez A, Ramírez E, Yébenes M, Muñoz A
Cost, time and errors assessment during preparation of parenteral nutrition: multichamber-bag versus hospital-compounded bags
J Parenter Enteral Nutr. 2019:43(4):557-565
![](https://porib.com/wp-content/uploads/2021/07/Public-Health.jpg)
Mareque M, Oyagüez I, Morano R, Casado MA
Systematic review of the literature on the epidemiology of herpes zoster: incidence in the general population and specific sub-population in Spain
Public Health 2019;167: 136-146
![](https://porib.com/wp-content/uploads/2021/06/farmacia_hospitalaria.jpg)
Cervera E, de Andrés-Nogales F, Armadá F, Arias L, Oyagüez I, Martinez C
Análisis de impacto presupuestario del implante intravítreo de dexametasona para el tratamiento del edema macular diabético
Farm Hosp. 2018;42(6):244-50
![](https://porib.com/wp-content/uploads/2021/07/Revista-Espanola-de-Salud-Publica.jpg)
Mareque M, Oliva J
Costes sociales de las enfermedades: ¿cuán relevantes son para las evaluaciones económicas?
Rev Esp Salud Pública. 2018; Vol. 92
![](https://porib.com/wp-content/uploads/2021/07/adicciones.jpg)
Bobes J, Pascual F, Sabater E, Colom J, Ferre F, Szerman N, Casado MA
Análisis de decisión multicriterio en programas de tratamiento de sustitución de opiáceos en trastornos por consumo de opiáceos
Adicciones 2018; 30(3):167-169
![](https://porib.com/wp-content/uploads/2021/06/pharmacoeconomics_spanish_research_articles-1.jpg)
Jiménez-Yuste V, Álvarez-Román MT, Mingot-Castellano ME, Fernández-Mosteirín N, Mareque M, Oyagüez I
Análisis de costes del tratamiento para pacientes con hemofilia A con inhibidor en España
PharmacoEcon Span Res Artic. 2018;15(1):25-34
![](https://porib.com/wp-content/uploads/2021/07/Journal-Antimicrobial-Chemotherapy.jpg)
Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to RPV/FTC/TDF due to intolerance to previous cART: the PRO-STR study
Journal Antimicrobial Chemotherapy.Doi: 10.1093/jac/dky175
![](https://porib.com/wp-content/uploads/2021/07/revista_espanola_de_economia_de_la_salud.jpg)
Casado MA, Echave M, Ruiz L, Oyagüez I